Innovative Drug Research Laboratories, Kyowa Hakko Kirin Co., Ltd., 3-6-6, Asahi-machi, Machida-shi, Tokyo, 194-8533, Japan.
Int J Cancer. 2010 Sep 1;127(5):1072-80. doi: 10.1002/ijc.25143.
MicroRNAs (miRNAs) are a class of small noncoding RNAs that negatively regulate expression of target mRNA. They are involved in many biological processes, including cell proliferation, apoptosis and differentiation, and considered as new therapeutic targets for cancers. In our study, we performed a gain-of-function screen using 319 miRNAs to identify those affecting cell proliferation and death in human colorectal cancer cells (DLD-1). We discovered a number of miRNAs that increased or decreased cell viability in DLD-1. They included known oncogenic miRNAs such as miR-372 and miR-373, and tumor suppressive miRNAs such as miR-124a, but also some for which this information was novel. Among them, miR-491 markedly decreased cell viability by inducing apoptosis. We demonstrated that Bcl-X(L) was a direct target of miR-491, and its silencing contributed to miR-491-induced apoptosis. Moreover, treatment of miR-491 suppressed in vivo tumor growth of DLD-1 in nude mice. Our study provides a new regulation of Bcl-X(L) by miR-491 in colorectal cancer cells, and suggests a therapeutic potential of miRNAs for treating colorectal cancer by targeting Bcl-X(L).
微小 RNA(miRNA)是一类负调控靶 mRNA 表达的小非编码 RNA。它们参与许多生物学过程,包括细胞增殖、凋亡和分化,被认为是癌症的新治疗靶点。在我们的研究中,我们使用 319 个 miRNA 进行了功能获得性筛选,以鉴定那些影响人结直肠癌细胞(DLD-1)增殖和死亡的 miRNA。我们发现了许多 miRNA 可增加或降低 DLD-1 中的细胞活力。其中包括已知的致癌 miRNA,如 miR-372 和 miR-373,以及肿瘤抑制 miRNA,如 miR-124a,但也有一些 miRNA 的信息是新的。其中,miR-491 通过诱导细胞凋亡显著降低细胞活力。我们证明 Bcl-X(L) 是 miR-491 的直接靶标,其沉默有助于 miR-491 诱导的凋亡。此外,miR-491 的抑制处理可抑制裸鼠中 DLD-1 的体内肿瘤生长。我们的研究提供了 miR-491 在结直肠癌细胞中对 Bcl-X(L) 的新调控,并提示 miRNA 通过靶向 Bcl-X(L) 治疗结直肠癌的治疗潜力。